Prasugrel also improved the risk of stent thrombosis in DM subgroup (all DM patients: 2.0% versus 3.6%; HR = 0.52; P = 0.007; insulin treated patients: 1.8% versus 5.7%; HR = 0.31; P = 0.008) [165]. Here, INS is linked to diabetes mellitus.